Studies and Progress of EGFR exon 20 Insertion Mutation in Non-small Cell Lung Cancer

Studies and Progress of EGFR exon 20 Insertion Mutation in Non-small Cell Lung Cancer

Lung cancer has the highest morbidity and mortality among malignant tumors worldwidely. Targeted therapy related to non-small cell lung cancer (NSCLC) is the research hotspot in recent year. The emergence of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) has brought a huge c...

Full description

Bibliographic Details
Main Authors: Wensheng ZHOU, Wei ZHANG, Baohui HAN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2020-02-01
Series:Chinese Journal of Lung Cancer
Subjects:
epidermal growth factor receptor
exon 20
lung neoplasms
insertion mutation
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2020.02.07

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2020.02.07

Similar Items